Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures

Authors

  • Deanna R. Worley

    Corresponding author
    1. Department of Clinical Sciences, Flint Animal Cancer Center, Colorado State University, Fort Collins, CO, USA
    • Correspondence address:

      D. R. Worley

      Flint Animal Cancer Center

      Colorado State University

      Fort Collins, CO, USA

      e-mail: deanna.worley@colostate.edu

    Search for more papers by this author

Abstract

The study hypothesis is that incorporation of sentinel lymph node (SLN) mapping in dogs presenting for mast cell tumour (MCT) removal would impact the recommended adjuvant therapy offered. Nineteen dogs were enrolled having either spontaneously occurring or incompletely excised MCTs. Staging included regional lymph node aspiration. SLN mapping was done with regional lymphoscintigraphy combined with intra-operative lymphoscintigraphy and blue dye. Twenty MCTs in 19 dogs were excised with SLN mapping. Eight dogs had SLNs different from the closest node. Twelve dogs had metastasis in extirpated SLNs, seven occurred in MCTs with a MI ≤ 5. No correlation was noted between patient stage and the c-KIT proto-oncogene. Because of SLN staging, 8 of 19 dogs were offered additional therapy that would have otherwise been excluded. Anatomic sampling of lymph nodes in dogs with MCTs does not accurately reflect which lymph nodes are most likely to be receiving the draining tumour lymph.

Ancillary